Targeting the cancer glycocalyx in salivary duct carcinoma: tumor‐associated mucin 1 (Tn‐MUC1) as a novel cell surface marker
Abstract Despite the use of targeted drugs for human epidermal growth factor receptor type 2 (HER2)‐positive salivary duct carcinoma (SDC) treatment, the overall prognosis for SDC remains poor. In this study, we aimed to investigate whether the glycocalyx of SDC cells serves as a potential cell surf...
שמור ב:
| Principais autores: | , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wiley
2025-09-01
|
| סדרה: | The Journal of Pathology: Clinical Research |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1002/2056-4538.70042 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
